Skip to main content

Currently Skimming:

Appendix C: Chronology of Important Events Regarding Vaccine Safety
Pages 170-174

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.

From page 170...
... _, Is ~ Measles vaccine allele 1967 1969 1971 1977 gums vaccine avaU~le RubeUa vaccine av~l~le easles-~u~s-RubeHa (WAR) vaccine av~l~le 1979 Current ~rmuladon of rubella vaccine av~l~le replaces earlier versions 1982 Plasma-de~ved bep~ds B .
From page 171...
... pertussis and rubella, 2) routine child vaccines 2 Hib conjugate vaccines licensed for use beginning at 2 months Evaluation of Poliomyelitis Vaccine Policy Options 1991 Acellular pertussis Hepatitis B Adverse Effects of Pertussis component licensed for the recommended by ACIP and Rubella Vaccines 4th and 5th doses of the for addition to 5-part DTP series in ACEL-IMUNE childhood immunization schedule ACIP recommends Hib be added to childhood immunization schedule 1992 Acellular pertussis Hepatitis B vaccine: component licensed for the Added universal 4th and 5th doses of the vaccination for all 5-part DTP series in infants, high-risk Tripedia adolescents (e.g., IV drug users, persons with multiple sex partners)
From page 172...
... licensed for first DTaP in place of DTP 4 doses of 5-part series 1998 Additional DTaP vaccine (Certiva) licensed for first 4 doses of 5-part series Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality DPT and Chronic Nervous System Dysfunction: A New Analysis Options for Poliomyelitis Vaccinations in the United States: Workshop Summary Vaccine Safety Forum: Summary of Two Workshops Risk Communication and Vaccination: Workshop Summary ACIP updates MMR recommendation, encouraging use of the combined MMR vaccine
From page 173...
... October: ACIP drafts statement expressing a preference for use of thimerosal-free DTaP, Hib, and Hep B vaccines by March 2002 Immunization Safety Review: Measles-MumpsRubella Vaccine and Autism Immunization Safety Review: ThimerosalContaining Vaccines and Neuro-developmental Disorders
From page 174...
... 174 IMMUNIZATION SAFETY REVIEW Vaccine Year Licensure Legislation and/or Policy Statements IOM Reports on Vaccine Safety 2002 Immunization Safety Review: Multiple Immunizations and Immune Dysfunction Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer 2003 Live attenuated intranasal ACIP recommends Immunization Safety influenza vaccine that children 6 to Review: Hepatitis B approved for use in the 23 months of age be Vaccine and Demyelinating United States in healthy vaccinated annually Neurological Disorders individuals aged against influenza 5-49 years old (FluMist) beginning in the Immunization Safety 2004-2005 influenza Review: SV40 season Contamination of Polio Vaccine and Cancer Immunization Safety Review: Vaccinations and Sudden Unexpected Death in Infancy l

This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.